FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide)

Snippet

SUPPL AP for BENICAR HCT (OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE)